ASCEPT student forum symposium 2020
October 20, 2020
November 5th – 6th
Abstract submission by 23rd October
Symposium will include selected student talks
(10 min) and a careers panel discussion
Advances in Urogenital and Gut Research Symposium
August 17, 2020
Continuing the successful series of “Advances in Urogenital Research”, held since 2004 join us for our annual symposium, which this year will be held virtually on Wednesday 30 September 2020 from 1.30 pm – 5.45 pm. FREE registration. Please register by Wednesday 23 September.
International societies call on researchers to apply clinical pharmacology principles in search for safe and effective treatments for COVID-19
June 10, 2020
The Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and the British Pharmacological Society have published a joint international statement calling on researchers to apply clinical pharmacology principles in search for safe and effective treatments for COVID-19. The statement was published in the British Journal of Clinical Pharmacology and endorsed by international organisations* across
COVID-19 Forum
April 3, 2020
The Executive has created a new special interest group forum for discussions on COVID-19. Members can now request access.
APFP 2020 Dates Changed
March 12, 2020
The organising committee of the 14th meeting of the Asia Pacific Federation of Pharmacologists have this week announced the change of date of the APFP meeting to September 27-30 2020. Click here to find out more. http://2020apfp.com/
Membership Announcement
December 17, 2019
It is with great sadness the ASCEPT Executive notify you that Professor Sir Alasdair Breckenridge passed away on 13 December 2019. He had been a member of BPS since 1971 and was elected to Honorary Fellowship in 2002. His contribution to the Society was longstanding, as was his contribution to clinical pharmacology. He was also a
ASCEPT member Stefanie Hennig new position
October 22, 2019
Dr. Stefanie Hennig joined Certara Strategic Consulting as an Associate Director of Consulting Service in July 2019. She will be working as a consultant in PK and PK/PD modelling and simulation in various phases of drug development in a variety of population groups.